Company / SG&A Expense
Teladoc Health, Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$431.9M
FY2025
5-year range
$431.9M / $464.7M
FY2021-FY2025
Trend
-0.8%
vs FY2024
Sector context
#72 of 152
Health Care
What the data says
At $432M, Teladoc Health, Inc.'s sg&a expense ranks #81 of 152 in the Health Care sector. SG&A Expense has fluctuated over the past 10 years, ranging from $49M in FY2016 to $507M in FY2020.
Based on SEC 10-K filings.
$432M in FY2025 with a 5-year CAGR of -3.1%.
Improved from $465M to $432M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -1.3%
- 5-Year CAGR
- -3.1%
- 10-Year CAGR
- -
Sector benchmark
#81 of 152 in Health CareTop 53% of 152This company $431.9M Sector average $182.7B
▼
-99.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -3.1%, indicating a declining trend.
- In FY2025, sg&a expense decreased 0.8% year-over-year.
- Ranks #72 out of 152 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -3.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $431.9M | -0.8% |
| FY2024 | $435.5M | -6.3% |
| FY2023 | $464.7M | +3.3% |
| FY2022 | $449.9M | +2.7% |
| FY2021 | $438.0M | -13.6% |
| FY2020 | $506.7M | +208.1% |
| FY2019 | $164.5M | +40.7% |
| FY2018 | $116.9M | +46.5% |
| FY2017 | $79.8M | +64.3% |
| FY2016 | $48.6M | +13.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026